4th Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lobbied on issues related to abuse deterrent formulation of drugs &prescription drug abuse. FDA proposed rule on generic drug labels S. 2948 Medicaid Generic Drug Price Fairness Act Lobbied on a policy related to incentives for New Therapeutic Entities
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special assistant to the President 2002-2005 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.